Waise, T
A 2024 review of PRP found that serious complications are uncommon, with mild, short-lived reactions making up the bulk of what patients report
Dual-Hormone Tracking Mounjaro activates both GLP-1 and GIP receptors for superior results
Clinical Trials for Incretin-Based Therapy Highlighting the medications healthcare professionals can expect to see coming into the pipeline this year and next, Donna Ryan, MD, Professor Emeritus, Clinical Science, Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, shared a robust overview of clinical trial data, including results from OASIS 1 and 4, STEP UP, and REDEFINE 1 and 2, reflecting the options and opportunities to better inform clinical decision-making
doi: 10.1096/fj.202201400R 29
doi: 10.1016/j.cell.2011.03.054 40 HuLZengZXiaQLiuZFengXChenJet al